Detalhe da pesquisa
1.
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(2): 223-234, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539742
2.
Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2.
Vaccines (Basel)
; 10(5)2022 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35632544
3.
Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group.
J Clin Oncol
; 37(31): 2835-2845, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31498753
4.
Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials.
Lancet Haematol
; 5(10): e462-e473, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30290903